E-LIB Suche - Ergebnisse für: Svoboda, Jakub

1

Weighted packet selection for rechargeable links in cryptoc..:

Schmid, Stefan ; Svoboda, Jakub ; Yeo, Michelle
Theoretical Computer Science. 989 (2024) - p. 114353 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and safety of bendamustine for lymphodepletion bef..:

Ghilardi, Guido ; Paruzzo, Luca ; Patel, Vrutti...
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Bendamustine lymphodepletion before axicabtagene ciloleucel..:

Ghilardi, Guido ; Paruzzo, Luca ; Svoboda, Jakub...
Blood Advances. 8 (2024) 3 - p. 653-666 , 2024

Link: https://doi.org/10.1182/..

4

Amplifiers of selection for the Moran process with both Bir..:

Svoboda, Jakub ; Joshi, Soham ; Tkadlec, Josef..
PLOS Computational Biology. 20 (2024) 3 - p. e1012008 , 2024

Link: https://doi.org/10.1371/..

5

Congestion-Free Rerouting of Network Flows: Hardness and an..:

, In: NOMS 2024-2024 IEEE Network Operations and Management Symposium,

Ceylan, Esra ; Chatterjee, Krishnendu ; Schmid, Stefan. - p. 1-7 , 2024

Link: https://doi.org/10.1109/..

6

Immunologic Predictors of Vaccine Responsiveness in Patient..:

Chong, Elise A ; Kumashie, Kingsley Gideon ; Chong, Emeline R...
The Journal of Infectious Diseases. 230 (2024) 1 - p. 15-27 , 2024

Link: https://doi.org/10.1093/..

7

Deterministic Sub-exponential Algorithm for Discounted-sum ..:

, In: Proceedings of the 39th Annual ACM/IEEE Symposium on Logic in Computer Science,

Asadi, Ali ; Chatterjee, Krishnendu ; Svoboda, Jakub. - p. 1-12 , 2024

Link: https://dl.acm.org/doi/1..

8

T cell lymphoma and secondary primary malignancy risk after..:

Ghilardi, Guido ; Fraietta, Joseph A. ; Gerson, James N....
Nature Medicine. 30 (2024) 4 - p. 984-989 , 2024

Link: https://doi.org/10.1038/..

9

Bendamustine as Lymphodepletion for Brexucabtagene Autoleuc..:

Chong, Elise A. ; Chong, Emeline R. ; Therwhanger, Dylan...
Transplantation and Cellular Therapy. 30 (2024) 7 - p. 726.e1-726.e8 , 2024

Link: https://doi.org/10.1016/..

10

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidenc..:

Bowers, Jackson T. ; Anna, Jacob ; Bair, Steven M....
Blood Advances. 7 (2023) 21 - p. 6630-6638 , 2023

Link: https://doi.org/10.1182/..

11

Low concentrations of acetamiprid, deltamethrin, and sulfox..:

Svoboda, Jakub ; Pech, Pavel ; Heneberg, Petr
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

12

TP53 mutations predict for poor outcomes in patients with n..:

Landsburg, Daniel J. ; Morrissette, Jennifer JD ; Nasta, Sunita D....
Blood Advances. 7 (2023) 23 - p. 7243-7253 , 2023

Link: https://doi.org/10.1182/..

13

Nine-year follow-up of lenalidomide plus rituximab as initi..:

Yamshon, Samuel ; Chen, Gui Zhen ; Gribbin, Caitlin...
Blood Advances. 7 (2023) 21 - p. 6579-6588 , 2023

Link: https://doi.org/10.1182/..

14

Development of the diagnostic tools for the COMPASS-U tokam..:

Weinzettl, Vladimir ; Bilkova, Petra ; Duran, Ivan...
Fusion Engineering and Design. 191 (2023) - p. 113545 , 2023

Link: https://doi.org/10.1016/..

15

Salvage radiotherapy for relapsed/refractory non‐Hodgkin ly..:

Yegya-Raman, Nikhil ; Wright, Christopher M. ; LaRiviere, Michael J....
Clinical and Translational Radiation Oncology. 39 (2023) - p. 100587 , 2023

Link: https://doi.org/10.1016/..